NO995004D0 - Anvendelse av bruskoligometrisk matriksprotein for behandling av reumatoid artritt - Google Patents

Anvendelse av bruskoligometrisk matriksprotein for behandling av reumatoid artritt

Info

Publication number
NO995004D0
NO995004D0 NO995004A NO995004A NO995004D0 NO 995004 D0 NO995004 D0 NO 995004D0 NO 995004 A NO995004 A NO 995004A NO 995004 A NO995004 A NO 995004A NO 995004 D0 NO995004 D0 NO 995004D0
Authority
NO
Norway
Prior art keywords
treatment
matrix protein
rheumatoid arthritis
oligomeric matrix
cartilage oligomeric
Prior art date
Application number
NO995004A
Other languages
English (en)
Other versions
NO995004L (no
Inventor
Dick Heinegord
Jonny C Lorentzen
Lars Klareskog
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO995004L publication Critical patent/NO995004L/no
Publication of NO995004D0 publication Critical patent/NO995004D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO995004A 1997-04-15 1999-10-14 Anvendelse av bruskoligometrisk matriksprotein for behandling av reumatoid artritt NO995004D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9701409A SE9701409D0 (sv) 1997-04-15 1997-04-15 Treatment of rheumatoid arthritis
PCT/SE1998/000682 WO1998046253A1 (en) 1997-04-15 1998-04-14 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis

Publications (2)

Publication Number Publication Date
NO995004L NO995004L (no) 1999-10-14
NO995004D0 true NO995004D0 (no) 1999-10-14

Family

ID=20406587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995004A NO995004D0 (no) 1997-04-15 1999-10-14 Anvendelse av bruskoligometrisk matriksprotein for behandling av reumatoid artritt

Country Status (21)

Country Link
EP (1) EP1019078B1 (no)
JP (1) JP2001520647A (no)
KR (1) KR20010006352A (no)
CN (1) CN1260721A (no)
AT (1) ATE245438T1 (no)
AU (1) AU746221B2 (no)
BR (1) BR9808591A (no)
CA (1) CA2286791A1 (no)
DE (1) DE69816634T2 (no)
EE (1) EE9900464A (no)
HU (1) HUP0002231A3 (no)
ID (1) ID24561A (no)
IL (1) IL132354A0 (no)
IS (1) IS5210A (no)
NO (1) NO995004D0 (no)
NZ (1) NZ338084A (no)
PL (1) PL336163A1 (no)
SE (1) SE9701409D0 (no)
SK (1) SK141399A3 (no)
TR (1) TR199902564T2 (no)
WO (1) WO1998046253A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849594B1 (en) * 1999-06-30 2005-02-01 John Lawler Purification and use of human recombinant cartilage oligomeric matrix protein
SE9904236D0 (sv) 1999-11-22 1999-11-22 Ana Mar Diagnostics Ab Immunoassay
KR100429288B1 (ko) * 2001-11-23 2004-04-29 장오기계 주식회사 전사인쇄장치
CN100417415C (zh) * 2006-06-28 2008-09-10 文彦春 浸润治疗关节炎的药物
WO2014003679A1 (en) 2012-06-28 2014-01-03 Anamar Ab Determining pathological cartilage turnover

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192744A (en) * 1990-01-12 1993-03-09 Northwestern University Method of inhibiting angiogenesis of tumors
US5872094A (en) * 1993-01-06 1999-02-16 The General Hospital Corporation Method for attaching cartilaginous tissue, cartilage matrix protein or link protein to a surface

Also Published As

Publication number Publication date
NO995004L (no) 1999-10-14
SE9701409D0 (sv) 1997-04-15
EE9900464A (et) 2000-04-17
SK141399A3 (en) 2000-08-14
BR9808591A (pt) 2000-05-23
ID24561A (id) 2000-07-27
WO1998046253A1 (en) 1998-10-22
ATE245438T1 (de) 2003-08-15
DE69816634T2 (de) 2004-06-03
NZ338084A (en) 2001-07-27
IS5210A (is) 1999-10-12
EP1019078B1 (en) 2003-07-23
CN1260721A (zh) 2000-07-19
HUP0002231A2 (hu) 2000-11-28
AU746221B2 (en) 2002-04-18
KR20010006352A (ko) 2001-01-26
HUP0002231A3 (en) 2002-09-30
JP2001520647A (ja) 2001-10-30
PL336163A1 (en) 2000-06-05
CA2286791A1 (en) 1998-10-22
EP1019078A1 (en) 2000-07-19
IL132354A0 (en) 2001-03-19
DE69816634D1 (de) 2003-08-28
TR199902564T2 (xx) 2000-02-21
AU7093898A (en) 1998-11-11

Similar Documents

Publication Publication Date Title
NO20006718L (no) Proteaseinhibitorer
HK1049103A1 (zh) 含有利托那韋(abt-538)並與茚地那韋(mk-639)結合藥物的組合物以及他們在治療艾滋病中的用途
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
MY119155A (en) New peptide derivatives
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
DE69507029D1 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
BR9913072A (pt) Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia
DE69426471D1 (de) Verwendung von Sulodexid und von Arzneimitteln, die dieses enthalten, zur Behandlung der diabetischen Nephropathie
BR9814945A (pt) Utilização de fanquinona para o tratamento de doença de alzheimer, composição farmacêutica e kit
NO995004D0 (no) Anvendelse av bruskoligometrisk matriksprotein for behandling av reumatoid artritt
IL113940A (en) Synthetic peptides which are elastase inhibitors and pharmaceutical compositions for the treatment of neutrophil associated inflammatory disease containing said inhibitors
YU60199A (sh) Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji
GR3033698T3 (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections.
WO2001014576A3 (en) Process and intermediates for the preparation of isoxazolecaroxamides and analogues
DE69718500D1 (de) (-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
PT907737E (pt) Muteina da il-6
OA09197A (fr) "Peptides SDK, leur procédé de préparation ainsi que des compositions thérapeutiques en contenant".
BR0010338A (pt) Composto enanciomericamente enriquecido, composição farmacêutica, método para tratar uma doença ou condição mediada por cck-a, uso de um composto, e, processo para a preparação de um composto
BR9906931A (pt) Triazepinonas, processo para sua preparação e sua aplicação terapêutica
UA30874A (uk) Спосіб профілактики полігіпомікроелементозу
MX9800686A (es) Nueva proteina hmw humana mp52s.
UA27023C2 (uk) Спосіб профілактики та лікуваhhя серцево-судиhhих захворюваhь

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application